David Tabano serves as the Senior Director and Value Evidence Customer Strategy Lead (VECSL) at Genentech. In this strategic position, David coordinates the relationship between evidence teams and customer-facing teams to leverage Health Economics and Outcomes Research (HEOR) for improved patient access decisions. David joined Genentech in 2020 and has diverse experience in the pharmaceutical industry, as well as in public health, managed care and state Medicaid organizations. David holds bachelors and masters degrees in Economics, and a PhD in Pharmaceutical Outcomes Research.